-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
June 01, 2010 - However, we more clearly identify where on the continuum of
prophylaxis-treatment-end-stage these studies … While some studies might hint towards an early
intervention (e.g., in prophylaxis use) in high-risk
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/data-extraction-google_research.pdf
January 01, 2013 - Cardiac function
Colorectal cancer
Diabetes mellitus education
Diabetes mellitus prevention
Fungal prophylaxis … [Comparison of micafungin and fosfluconazole as
prophylaxis for invasive fungal infection during neutropenia … Medium intensity oral anticoagulants
versus aspirin after cerebral ischaemia of arterial origin (ESPRIT
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
January 01, 2015 - estimated 2.7 million to 6.1 million patients who currently have
AF have one or more contraindications to anticoagulants … About half of the patients with
contraindications to anticoagulants (550,000 to 1.2 million) are at … expected to be diagnosed each year, and
if 40% (64,000) of these new cases have contraindications to anticoagulants … Centers for Disease Control and Prevention (CDC) recommends pre-exposure
prophylaxis (PrEP) for males
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
September 01, 2010 - of strategies to optimize benefits and minimize harms, such as the
concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a
tamoxifen prophylaxis decision aid: the
debiasing influence … Future trials could evaluate the
benefits and harms of using tamoxifen or raloxifene with an anticoagulant
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - of strategies to optimize benefits and minimize harms, such as the
concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a
tamoxifen prophylaxis decision aid: the
debiasing influence of … Future trials could evaluate the
benefits and harms of using tamoxifen or raloxifene with an anticoagulant
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
January 01, 2012 - Unless researchers know the harms of an intervention a priori (e.g.,
bleeding with anticoagulants), … the American College of Chest
Physicians present NNTs based on a systematic review of RCTs of oral anticoagulant … Advances in risk-benefit
evaluation using probabilistic simulation methods:
an application to the prophylaxis